Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2021 December;87(12) > Minerva Anestesiologica 2021 December;87(12):1359-66

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

EXPERTS’ OPINION   Free accessfree

Minerva Anestesiologica 2021 December;87(12):1359-66

DOI: 10.23736/S0375-9393.21.15827-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Tier-three therapies for refractory intracranial hypertension in adult head trauma

Chiara ROBBA 1, 2 , Francesca IANNUZZI 1, Fabio S. TACCONE 3

1 Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy; 2 IRCCS Ospedale Policlinico San Martino, Genoa, Italy; 3 Department of Intensive Care Medicine, Erasme Hospital, University of Brussels, Brussels, Belgium



Refractory intracranial hypertension after traumatic brain injury (TBI) is defined as recurrent increase of intracranial pressure above 20-22 mmHg for sustained period of time (10-15 min), despite conventional therapies, such as osmotic therapy, cerebral spinal fluid drainage and mild hyperventilation. As such, more aggressive treatments should be taken into consideration. In particular, therapeutic hypothermia, barbiturates administration and decompressive craniectomy are considered as tier-three or “salvage” interventions, as they have shown to be able to control refractory hypertension; however, they are also associated with an increased risk of significant side effects. Therefore, the aim of this review was to describe the evidence supporting the use of these tier-three therapies in the management of refractory intracranial hypertension in TBI patients.


KEY WORDS: Brain injuries, traumatic; Barbiturates; Decompressive craniectomy; Hypothermia

inizio pagina